Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society’s recommendations for best clinical practice-Reference-Cited by-同舟云学术

Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society’s recommendations for best clinical practice

Published:2024-09-07 Issue: Volume: Page:
ISSN:2049-4637
Container-title:British Journal of Pain
language:en
Short-container-title:British Journal of Pain

Author:

Eldabe Sam¹,Duarte Rui²³^ORCID,Thomson Simon⁴,Bojanic Stana⁵,Farquhar-Smith Paul⁶,Bagchi Somnath⁷,Farquhar Lis⁸^ORCID,Wetherill Bill⁹,Copley Sue¹^ORCID

Affiliation:

1. Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK

2. Liverpool Reviews and Implementation Group, Department of Health Data Science, University of Liverpool, Liverpool, UK

3. Saluda Medical Pty Ltd, Artarmon, NSW, Australia

4. Pain Medicine and Neuromodulation, Mid & South Essex University Hospitals, Essex, UK

5. Department of Neurosurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

6. Department of Anaesthesia, Perioperative Medicine, Pain and Critical Care, The Royal Marsden NHS Foundation Trust, London, UK

7. Pain Medicine, University Hospitals Plymouth NHS Trust, Plymouth, UK

8. Pain Management Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK

9. Main Pharmacy, The James Cook University Hospital, Middlesbrough, UK

Abstract

The British Pain Society updated their recommendations on intrathecal drug delivery (ITDD) for the management of pain and spasticity in adults. The recommendations are primarily evidence based but where necessary comprise the consensus opinion of the working group. The recommendations are accompanied by information for patients and their carers, intended to inform and support patients in their decision making. The updated guidance includes recent evidence base of ITDD use in pain and spasticity, address the issues of drug pump compatibility following the latest manufacturer and Medicines and Healthcare products Regulatory Agency (MHRA) recommendations as well as provide an update on the indications and complication management particularly endocrine complications and intrathecal granuloma formation.

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/20494637241280356

Reference214 articles.

1. Opiate Receptor: Demonstration in Nervous Tissue

2. Analgesia Mediated by a Direct Spinal Action of Narcotics

3. SELECTIVE SPINAL ANALGESIA

4. EPIDURAL MORPHINE IN TREATMENT OF PAIN

5. Pain Relief by Intrathecally Applied Morphine in Man